Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET

Mediterr J Hematol Infect Dis. 2012;4(1):e2012041. doi: 10.4084/MJHID.2012.041. Epub 2012 Jun 18.

Abstract

A 71 year old female with multiple myeloma presented with back pain seven year after autologous stem cell transplant. Skeletal bone survey and magnetic resonance imaging did not show a relapse that was evidenced by CT/PET. Lenalidomide as single agent induced a complete disappearance of the lesions 6 months later and confirmed after one year at CT/PET.

Publication types

  • Case Reports